Incidental Discovery of Ochronosis During Total Knee Arthroplasty: A Case Report and Literature Review Authors: Augustin Demain, Etienne Willemart Published: 2026 ABSTRACT Ochronosis is a rare disease that causes rapid and severe destruction of large joints, and joint replacement is often required in advanced stages. Due to the rarity and lack of awareness of this condition, diagnosis is often made during surgery. We present the case of a 54-year-old woman who underwent knee arthroplasty with the incidental discovery of a black knee. Concerned by this situation, we aimed to review the available literature to assess functional outcomes and implant survivorship in this rare condition. Despite the low level of evidence in the literature, it would appear that total knee arthroplasty in ochronosis leads to good results in terms of pain relief and functional scores, and most importantly implant survivorship is comparable to that of the general population. Introduction Ochronosis is the systemic manifestation of a rare autosomal recessive metabolic disease called alkaptonuria (AKU) [1]. This disorder results from a deficiency of the enzyme homogentisate 1,2-dioxygenase, leading to accumulation of homogentisic acid (HGA) [[1], [2], [3]]. Once oxidized, this metabolite from the tyrosine degradation pathway transforms into a melanin-like polymer known as ochronotic pigment [3]. While the only clinical sign in childhood is often dark discoloration of the urine, the natural decline in renal clearance starting around the third to fourth decade of life reduces urinary excretion capacity [4,5]. HGA concentrations increase and accumulate in collagen-rich connective tissues, affecting multiple organs such as the cartilage of large joints (hips, knees, shoulders), intervertebral discs, tendons, heart valves, vessel walls, the skin, and the sclerae [4]. From a musculoskeletal standpoint, HGA accumulation leads to the loss of mechanical properties of connective tissues, rendering the cartilage rigid and brittle [4]. Inflammatory phenomena involving the release of free radicals will accelerate joint degradation, causing severe and early ochronotic osteoarthritis [4,5]. Total knee arthroplasty is therefore often required in advanced stages of the disease [6]. The dual challenge of ochronosis is that the disease is often discovered incidentally and is extremely rare. As a result, there is a general lack of knowledge about this disease and its pathophysiology, making its discovery during surgery surprising and distressing. The objective of this article is to describe a case of incidental discovery of ochronosis and to provide guidance for performing total knee arthroplasty in such situations. Ethics approval and consent to participate This study is a single-patient case report. According to institutional and national regulations, ethics committee approval is not required for isolated case reports. Written informed consent was obtained from the patient for publication of this case report and all accompanying clinical and intraoperative images. Case history A 54-year-old female patient (body mass index: 24 kg/m2) with no significant medical history other than post-traumatic epilepsy (1996), treated and stable, presented to the orthopaedic clinic with bilateral knee pain, more pronounced on the right side. Despite a well-managed course of treatment, including oral anti-inflammatory drugs, physiotherapy, intra-articular corticosteroid injections, and viscosupplementation, the patient became increasingly disabled and unresponsive to medical treatment. Her walking distance was progressively reduced, and the pain was waking her during the night. The patient describes climbing stairs on all fours and being unable to walk more than a few dozen meters without stopping. She also reported recurrent joint effusions requiring joint aspiration of approximately 40 mL of straw-colored fluid. Clinical examination revealed a swollen right knee with a significant joint effusion and limited range of motion at −15°/115°. Preoperative radiographs showed a valgus phenotype with tricompartmental osteoarthritis, especially with complete chondrolysis of the lateral femorotibial compartment as well as the patellofemoral compartment (Fig. 1).Figure 1Preoperative anteroposterior, lateral, and skyline patellofemoral x-rays of the right knee demonstrating valgus alignment and advanced tricompartmental osteoarthritis with complete lateral cartilage loss. Preoperative anteroposterior, lateral, and skyline patellofemoral x-rays of the right knee demonstrating valgus alignment and advanced tricompartmental osteoarthritis with complete lateral cartilage loss. Total knee arthroplasty of the right knee was proposed in July 2022. On the day of surgery, after performing a medial parapatellar arthrotomy, we were astonished to discover a jet-black joint with hypertrophic, brownish, severely inflamed synovium. Two legitimate questions immediately arose: what pathological entity were we facing and could we safely implant a prosthesis? We decided to take multiple samples for pathology and microbiology. A subtotal synovectomy was performed, followed by implantation of a posterior-stabilized total knee prosthesis (Depuy Synthes Attune) with patellar resurfacing and cemented components (Palacos). The immediate postoperative course was uneventful. The patient was mobilized on the same day as the procedure and allowed to stand with full weight-bearing as tolerated on the first postoperative day. No wound complications, infections, thromboembolic events, or neurovascular deficits were observed. She was transferred to a rehabilitation center on the second postoperative day to follow a standard rehabilitation program. About 10 days later, histologic examination revealed ochronotic pigment deposition within the synovial and cartilaginous tissues, associated with chronic inflammatory changes. No evidence of infection or malignancy was identified. At 6-month follow-up, clinical examination showed a well-healed surgical incision without signs of infection or effusion and a satisfactory range of motion at 0°/120°. Eighteen months after the first procedure, the patient underwent total knee arthroplasty on the left side. The same black discoloration of cartilage was noted (Fig. 2), and the arthroplasty was performed using the same operative technique and similar implants (Fig. 3). Postoperative recovery was free of significant complications, and 6-month follow-up showed a well-healed surgical incision without signs of infection or effusion and a range of motion of 0°/110°.Figure 2Intraoperative photos following arthrotomy of the left knee, showing characteristic black pigmentation of cartilage and ochronotic involvement of synovial tissue.Figure 3Postoperative anteroposterior and lateral x-rays of the right and left knees demonstrating appropriate implant positioning and alignment. Intraoperative photos following arthrotomy of the left knee, showing characteristic black pigmentation of cartilage and ochronotic involvement of synovial tissue. Postoperative anteroposterior and lateral x-rays of the right and left knees demonstrating appropriate implant positioning and alignment. New Knee Score Society 2011 assessments were performed at 3 years for the right knee and 2 years for the left knee, showing excellent results. For the right knee: objective score of 99/100, satisfaction score of 40/40, expectation score of 15/15, and functional score of 91/100. For the left knee: objective score of 97/100, satisfaction score of 40/40, expectation score of 15/15, and functional score of 95/100. The patient reported very high satisfaction with the surgical outcomes and described a marked improvement in pain and quality of life. Discussion AKU is a rare autosomal recessive disease with a global incidence ranging from 1/250,000 to 1/1,000,000. Regions most affected appear to be the Dominican Republic and Slovakia, where incidence reaches 1/19,000 [2]. Ochronotic osteoarthritis mainly affects large joints (hips, knees, shoulders), but one of the first anatomical regions involved is the axial skeleton, showing calcification of intervertebral discs and nucleus pulposus [2,4,5]. These patients are often misdiagnosed with ankylosing spondylitis [5]. In joints, HGA accumulation has 2 main consequences in addition to black pigmentation: loss of mechanical tissue properties due to stiffening, and release of free radicals causing chronic inflammation and development of severe, early osteoarthritis [4]. Most reports in the literature describe incidental intraoperative discoveries during meniscectomies, arthroplasties, discectomies, or arthrodeses. Diagnosis is almost always made postoperatively. Although it is possible to perform genetic testing for loss-of-function mutations on chromosome 3q [2,3], clinical presentation and urinary HGA measurement are sufficient for a definitive diagnosis [3,4]. Patients with AKU typically show bluish-black discoloration of the sclera and auricular cartilage, and sometimes even skin pigmentation. In our patient’s case, she presented scleral and auricular pigmentation (Fig. 4) [2,7]. Also, the patient recalls noticing dark urine on several occasions, but there is no family history of AKU. If we had been more aware of this disease, a simple observation of her facial features could have suggested the diagnosis.Figure 4Bluish-black pigmentation of the patient’s sclerae and auricular cartilage, characteristic of ochronosis. Bluish-black pigmentation of the patient’s sclerae and auricular cartilage, characteristic of ochronosis. Once the diagnosis is made, patients should be referred for cardiology, urology, and endocrinology for evaluation [[1], [2], [3]]. For further exploration of the specific genetic mutation and possible family studies, referral to a geneticist is appropriate [1,3]. Because of the degenerative and progressive nature of the disease, regular follow-up—particularly cardiovascular—is necessary. Valvulopathy, coronary artery calcification, and increased risk of cerebrovascular events were described [[1], [2], [3],5]. To date, no curative medical treatment exists [1]. Preventive measures commonly found in the literature include a low-protein diet, vitamin C, and nitisinone, which has been shown to reduce urinary HGA levels by 95% [2]. This treatment was approved by the European Medicines Agency in 2021 and recently approved by the U.S. Food and Drug Administration. Feasibility and outcomes of total knee arthroplasty in ochronosis When specifically reviewing total knee arthroplasty in the context of ochronosis, several articles provide literature reviews compiling multiple cases with varying follow-up durations. Unfortunately, due to its rarity, there are no prospective studies and existing series consist only of multiple small case reports with low levels of evidence (level 4–5) [6]. However, what consistently emerges is that total knee arthroplasty for ochronotic osteoarthritis significantly improves functional scores and offers acceptable recovery of joint range of motion [[7], [8], [9], [10]]. Furthermore, implant survivorship appears comparable to arthroplasties for osteoarthritis in the general population [6,8,9]. This comparable survivorship may be explained histologically: subchondral bone is not affected in this condition [8,11]. Regarding intraoperative difficulties and complications, the most frequently reported issues include stiffness of the extensor mechanism, making patellar exposure difficult. One case of patellar tendon rupture was reported by Spencer et al [9]. Additionally, inflammatory synovial hypertrophy may significantly increase intraoperative bleeding when subtotal synovectomy is indicated [10,11]. Choice of implant and surgical technique Due to potential difficulty with patellar exposure, a medial parapatellar approach is recommended. Given the degenerative nature of the disease, long-term reliability of the posterior cruciate ligament—and, to a lesser degree, the collateral ligaments—cannot be guaranteed. Posteriorly stabilized implants are a possible option [12], nonetheless medial pivot or congruent inserts may all be appropriate depending on intraoperative findings and surgeon preference. The same applies to patellar resurfacing. Some authors [12] classify ochronosis in the same category as rheumatoid arthritis, for which patella resurfacing is strongly recommended; however, it is not possible to state this with scientific certainty in the case of ochronosis due to a lack of evidence. The main objective is to remove as much diseased tissue as possible to reduce inflammatory burden. Regarding cemented vs uncemented fixation, available data are insufficient to draw firm conclusions [8,12,13]. However, subchondral bone is not affected [8]. In 2020, Rajkumar et al. reviewed 16 patients and 27 arthroplasties (hips and knees) and found no difference in functional or radiological outcomes between cemented and uncemented implants. In the general population, a meta-analysis on this issue also found no difference in implant survivorship between cemented and uncemented prosthesis [14]. A second meta-analysis focusing on posterior-stabilized implants similarly concluded no difference between the 2 groups [15]. Thus, although some authors (Lee WC et al.) recommend cemented fixation due to chronic inflammation, others report good results using uncemented implants [16]. The absence of subchondral bone involvement allows the surgeon to choose fixation on a case-by-case basis according to underlying bone quality. Summary Ochronotic osteoarthritis is a rare condition, most often discovered incidentally. Diagnosis is frequently made postoperatively. Patients with AKU will inevitably progress toward major joint destruction, indicating the need for total joint arthroplasty. Orthopaedic surgeons are therefore often the first to manage these patients. Arthroplasty provides functional results and implant survivorship comparable to the general population. Implant selection and patellar management should be individualized according to intraoperative findings and surgeon judgment. Conflicts of interest The authors declare there are no conflicts of interest. For full disclosure statements refer to https://doi.org/10.1016/j.artd.2026.102069. Informed patient consent The author(s) confirm that written informed consent has been obtained from the involved patient(s) or if appropriate from the parent, guardian, power of attorney of the involved patient(s); and, they have given approval for this information to be published in this case report (series). CRediT authorship contribution statement Augustin Demain: Writing – review & editing, Writing – original draft, Visualization, Investigation, Conceptualization, Data curation. Etienne Willemart: Writing – review & editing, Supervision, Investigation.